{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:04:58Z","timestamp":1784253898255,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"he Joint Special Project of Traditional Chinese Medicine of Basic Research Program of Science and Technology Department of Yunnan Province","award":["202101AZ070001-321"],"award-info":[{"award-number":["202101AZ070001-321"]}]},{"name":"he Joint Special Project of Traditional Chinese Medicine of Basic Research Program of Science and Technology Department of Yunnan Province","award":["202101AZ070001-321"],"award-info":[{"award-number":["202101AZ070001-321"]}]},{"name":"he Joint Special Project of Traditional Chinese Medicine of Basic Research Program of Science and Technology Department of Yunnan Province","award":["202101AZ070001-321"],"award-info":[{"award-number":["202101AZ070001-321"]}]},{"name":"he Joint Special Project of Traditional Chinese Medicine of Basic Research Program of Science and Technology Department of Yunnan Province","award":["202101AZ070001-321"],"award-info":[{"award-number":["202101AZ070001-321"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-026-05421-3","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T04:24:52Z","timestamp":1779683092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Yajieshaba extract improves alcohol\u2011induced liver injury by regulating hepatic lipid metabolism and gut microbiota"],"prefix":"10.1186","volume":"26","author":[{"given":"Yang","family":"Liping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xingzhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duan","family":"Xiaohua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"36","key":"5421_CR1","doi-asserted-by":"publisher","first-page":"12908","DOI":"10.3748\/wjg.v20.i36.12908","volume":"20","author":"JA Williams","year":"2014","unstructured":"Williams JA, Manley S, Ding WX. New advances in molecular mechanisms and emerging therapeutic targets in alcoholic liver diseases. World J Gastroenterol. 2014;20(36):12908\u201333. https:\/\/doi.org\/10.3748\/wjg.v20.i36.12908.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"5421_CR2","doi-asserted-by":"publisher","first-page":"G889","DOI":"10.1152\/ajpgi.00161.2019","volume":"318","author":"M Giuffre","year":"2020","unstructured":"Giuffre M, Campigotto M, Campisciano G, Comar M, Croce LS. A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature. Am J Physiol Gastrointest Liver Physiol. 2020;318(5):G889\u2013906. https:\/\/doi.org\/10.1152\/ajpgi.00161.2019.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"5421_CR3","doi-asserted-by":"publisher","unstructured":"Jiang LSB. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda). 2020;35(4):261\u201374. https:\/\/doi.org\/10.1152\/physiol.00005.2020","DOI":"10.1152\/physiol.00005.2020"},{"issue":"4","key":"5421_CR4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ajpath.2015.11.017","volume":"186","author":"IA Kirpich","year":"2016","unstructured":"Kirpich IA, Petrosino J, Ajami N, Feng W, Wang Y, Liu Y, et al. Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease. Am J Pathol. 2016;186(4):765\u201376. https:\/\/doi.org\/10.1016\/j.ajpath.2015.11.017.","journal-title":"Am J Pathol"},{"issue":"5","key":"5421_CR5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/gutjnl-2015-311014","volume":"65","author":"H Tilg","year":"2016","unstructured":"Tilg H, Mathurin P. Altered intestinal microbiota as a major driving force in alcoholic steatohepatitis. Gut. 2016;65(5):728\u20139. https:\/\/doi.org\/10.1136\/gutjnl-2015-311014.","journal-title":"Gut"},{"key":"5421_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.redox.2018.07.012","volume":"18","author":"YE Cho","year":"2018","unstructured":"Cho YE, Song BJ. Pomegranate prevents binge alcohol-induced gut leakiness and hepatic inflammation by suppressing oxidative and nitrative stress. Redox Biol. 2018;18:266\u201378. https:\/\/doi.org\/10.1016\/j.redox.2018.07.012.","journal-title":"Redox Biol"},{"issue":"3","key":"5421_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2008.10.028","volume":"50","author":"A Keshavarzian","year":"2009","unstructured":"Keshavarzian A, Farhadi A, Forsyth CB, Rangan J, Jakate S, Shaikh M, et al. Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats. J Hepatol. 2009;50(3):538\u201347. https:\/\/doi.org\/10.1016\/j.jhep.2008.10.028.","journal-title":"J Hepatol"},{"issue":"1","key":"5421_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148(1):30\u20136. https:\/\/doi.org\/10.1053\/j.gastro.2014.10.042.","journal-title":"Gastroenterology"},{"issue":"1","key":"5421_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/hep.24018","volume":"53","author":"AW Yan","year":"2011","unstructured":"Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology. 2011;53(1):96\u2013105. https:\/\/doi.org\/10.1002\/hep.24018.","journal-title":"Hepatology"},{"issue":"4","key":"5421_CR10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.jhep.2016.11.008","volume":"66","author":"G Ferrere","year":"2017","unstructured":"Ferrere G, Wrzosek L, Cailleux F, Turpin W, Puchois V, Spatz M, et al. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. J Hepatol. 2017;66(4):806\u201315. https:\/\/doi.org\/10.1016\/j.jhep.2016.11.008.","journal-title":"J Hepatol"},{"issue":"5","key":"5421_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander C, Adolph TE, Wieser V, Lowe P, Wrzosek L, Gyongyosi B, et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018;67(5):891\u2013901. https:\/\/doi.org\/10.1136\/gutjnl-2016-313432.","journal-title":"Gut"},{"issue":"7","key":"5421_CR12","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1111\/liv.14483","volume":"40","author":"M Sangineto","year":"2020","unstructured":"Sangineto M, Grabherr F, Adolph TE, Grander C, Reider S, Jaschke N, et al. Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease. Liver Int. 2020;40(7):1610\u20139. https:\/\/doi.org\/10.1111\/liv.14483.","journal-title":"Liver Int"},{"issue":"2","key":"5421_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s2225-4110(16)30084-0","volume":"2","author":"KHL Liu","year":"2012","unstructured":"Liu KHL, Raghu CT, Sheen R. Therapeutic potential of chinese herbal medicines in alcoholic liver disease. J Tradit Complement Med. 2012;2(2):115\u201322. https:\/\/doi.org\/10.1016\/s2225-4110(16)30084-0.","journal-title":"J Tradit Complement Med"},{"issue":"Pt A","key":"5421_CR14","doi-asserted-by":"publisher","first-page":"116921","DOI":"10.1016\/j.jep.2023.116921","volume":"318","author":"YMBFFLLJ Z","year":"2024","unstructured":"Z YMBFFLLJ, W Y. Yajieshaba prevents acute alcoholic liver injury and repairs the intestinal mucosal barrier. J Ethnopharmacol. 2024;318(Pt A):116921. https:\/\/doi.org\/10.1016\/j.jep.2023.116921.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"5421_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0254-6272(15)30028-5","volume":"35","author":"xh Duan","year":"2015","unstructured":"Duan xh, Hui Zj, Haifeng W, Chao C, Yu Z. Effect of Yajieshaba, a preparation of Dai indigenous medicine, on enhanced liver detoxification. J Tradit Chin Med. 2015;35(2):197\u2013205. https:\/\/doi.org\/10.1016\/s0254-6272(15)30028-5.","journal-title":"J Tradit Chin Med"},{"issue":"5","key":"5421_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.19852\/j.cnki.jtcm.2022.05.005","volume":"42","author":"L Yang","year":"2022","unstructured":"Yang L, Yu X, Zhang C, Chen P, Duan X. Yajieshaba prevents lipopolysaccharide-induced intestinal barrier injuryanti-inflammatory and anti-apoptosis. J Tradit Chin Med. 2022;42(5):707\u201314. https:\/\/doi.org\/10.19852\/j.cnki.jtcm.2022.05.005.","journal-title":"J Tradit Chin Med"},{"issue":"3","key":"5421_CR17","first-page":"29","volume":"15","author":"L Yu","year":"2009","unstructured":"Yu L, Lin Y. Combined treatment of Pa Ya An (alcoholic hepatitis) by Dai Chinese medicine. J Med Chin Minorities. 2009;15(3):29\u201330.","journal-title":"J Med Chin Minorities"},{"issue":"2","key":"5421_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0254-6272(15)30028-5","volume":"35","author":"D Xiaohua","year":"2015","unstructured":"Xiaohua D, Jin Z, Hui W, Haifeng C, Chao Z, Zepu Y. Effect of Yajieshaba, a preparation of Dai indigenous medicine, on enhanced liver detoxification. J Tradit Chin Med. 2015;35(2):197\u2013205. https:\/\/doi.org\/10.1016\/s0254-6272(15)30028-5.","journal-title":"J Tradit Chin Med"},{"key":"5421_CR19","doi-asserted-by":"publisher","first-page":"1124015","DOI":"10.3389\/fphar.2023.1124015","volume":"14","author":"Y Bai","year":"2023","unstructured":"Bai Y, Wu H, Zheng L, Xie Y, Liu F, Wan Y, et al. Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathway. Front Pharmacol. 2023;14:1124015. https:\/\/doi.org\/10.3389\/fphar.2023.1124015.","journal-title":"Front Pharmacol"},{"key":"5421_CR20","doi-asserted-by":"publisher","first-page":"1074286","DOI":"10.3389\/fphar.2022.1074286","volume":"13","author":"HMW Liu","year":"2022","unstructured":"Liu HMW, Zhao D, Ma Z, Zhang W, Chen Z, Li Z, Zhao P. Study on mechanism of action of total flavonoids from Cortex Juglandis Mandshuricae against alcoholic liver disease based on gut-liver axis. Front Pharmacol. 2022;13:1074286. https:\/\/doi.org\/10.3389\/fphar.2022.1074286.","journal-title":"Front Pharmacol"},{"key":"5421_CR21","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3389\/fmicb.2018.01874","volume":"9","author":"G Wang","year":"2018","unstructured":"Wang G, Liu Q, Guo L, Zeng H, Ding C, Zhang W, et al. Gut Microbiota and Relevant Metabolites Analysis in Alcohol Dependent Mice. Front Microbiol. 2018;9:1874. https:\/\/doi.org\/10.3389\/fmicb.2018.01874.","journal-title":"Front Microbiol"},{"issue":"4","key":"5421_CR22","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ajcn\/88.4.1097","volume":"88","author":"PI Alatalo","year":"2008","unstructured":"Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemela OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr. 2008;88(4):1097\u2013103. https:\/\/doi.org\/10.1093\/ajcn\/88.4.1097.","journal-title":"Am J Clin Nutr"},{"key":"5421_CR23","doi-asserted-by":"publisher","unstructured":"Seitz HK, Neuman MG. The History of Alcoholic Liver Disease: From an Unrecognized Disease to One of the Most Frequent Diseases in Hepatology. J Clin Med. 2021;10(4). https:\/\/doi.org\/10.3390\/jcm10040858.","DOI":"10.3390\/jcm10040858"},{"issue":"3","key":"5421_CR24","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","volume":"26","author":"L An","year":"2022","unstructured":"An L, Wirth U, Koch D, Schirren M, Drefs M, Koliogiannis D, et al. The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases. J Gastrointest Surg. 2022;26(3):671\u201383. https:\/\/doi.org\/10.1007\/s11605-021-05188-7.","journal-title":"J Gastrointest Surg"},{"key":"5421_CR25","doi-asserted-by":"publisher","first-page":"840752","DOI":"10.3389\/fmed.2022.840752","volume":"9","author":"L Chen","year":"2022","unstructured":"Chen L, Zhu Y, Hou X, Yang L, Chu H. The Role of Gut Bacteria and Fungi in Alcohol-Associated Liver Disease. Front Med (Lausanne). 2022;9:840752. https:\/\/doi.org\/10.3389\/fmed.2022.840752.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"5421_CR26","doi-asserted-by":"publisher","first-page":"1782157","DOI":"10.1080\/19490976.2020.1782157","volume":"12","author":"L Maccioni","year":"2020","unstructured":"Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, et al. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 2020;12(1):1782157. https:\/\/doi.org\/10.1080\/19490976.2020.1782157.","journal-title":"Gut Microbes"},{"key":"5421_CR27","doi-asserted-by":"publisher","first-page":"175628482094261","DOI":"10.1177\/1756284820942616","volume":"13","author":"C Skinner","year":"2020","unstructured":"Skinner C, Thompson AJ, Thursz MR, Marchesi JR, Vergis N. Intestinal permeability and bacterial translocation in patients with liver disease, focusing on alcoholic aetiology: methods of assessment and therapeutic intervention. Th Adv Gastroenterol. 2020;13:1756284820942616. https:\/\/doi.org\/10.1177\/1756284820942616.","journal-title":"Th Adv Gastroenterol"},{"issue":"12","key":"5421_CR28","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1136\/gutjnl-2016-312729","volume":"65","author":"H Tilg","year":"2016","unstructured":"Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut. 2016;65(12):2035\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2016-312729.","journal-title":"Gut"},{"issue":"6","key":"5421_CR29","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.3892\/mmr.2014.2126","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang Y, Tong J, Chang B, Wang B, Zhang D, Wang B. Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins. Mol Med Rep. 2014;9(6):2352\u20136. https:\/\/doi.org\/10.3892\/mmr.2014.2126.","journal-title":"Mol Med Rep"},{"issue":"1","key":"5421_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41538-022-00145-3","volume":"6","author":"L Qiao","year":"2022","unstructured":"Qiao L, Zhang X, Pi S, Chang J, Dou X, Yan S, et al. Dietary supplementation with biogenic selenium nanoparticles alleviate oxidative stress-induced intestinal barrier dysfunction. NPJ Sci Food. 2022;6(1):30. https:\/\/doi.org\/10.1038\/s41538-022-00145-3.","journal-title":"NPJ Sci Food"},{"issue":"9","key":"5421_CR31","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1039\/c9fo01415b","volume":"10","author":"J Fan","year":"2019","unstructured":"Fan J, Wang Y, You Y, Ai Z, Dai W, Piao C, et al. Fermented ginseng improved alcohol liver injury in association with changes in the gut microbiota of mice. Food Funct. 2019;10(9):5566\u201373. https:\/\/doi.org\/10.1039\/c9fo01415b.","journal-title":"Food Funct"},{"issue":"8","key":"5421_CR32","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/jgh.16199","volume":"38","author":"MH Jew","year":"2023","unstructured":"Jew MH, Hsu CL. Alcohol, the gut microbiome, and liver disease. J Gastroenterol Hepatol. 2023;38(8):1205\u201310. https:\/\/doi.org\/10.1111\/jgh.16199.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"5421_CR33","doi-asserted-by":"publisher","first-page":"223","DOI":"10.35946\/arcr.v37.2.07","volume":"37","author":"PA Engen","year":"2015","unstructured":"Engen PA, Green SJ, Voigt RM, Forsyth CB, Keshavarzian A. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Res. 2015;37(2):223\u201336.","journal-title":"Alcohol Res"},{"issue":"9","key":"5421_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"NR Shin","year":"2015","unstructured":"Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015;33(9):496\u2013503. https:\/\/doi.org\/10.1016\/j.tibtech.2015.06.011.","journal-title":"Trends Biotechnol"},{"key":"5421_CR35","doi-asserted-by":"publisher","unstructured":"Vital M, Karch A, Pieper DH. Colonic Butyrate-Producing Communities in Humans: an Overview Using Omics Data. mSystems. 2017;2(6). https:\/\/doi.org\/10.1128\/mSystems.00130-17.","DOI":"10.1128\/mSystems.00130-17"},{"issue":"1","key":"5421_CR36","doi-asserted-by":"publisher","first-page":"1946367","DOI":"10.1080\/19490976.2021.1946367","volume":"13","author":"R Singhal","year":"2021","unstructured":"Singhal R, Donde H, Ghare S, Stocke K, Zhang J, Vadhanam M, et al. Decrease in acetyl-CoA pathway utilizing butyrate-producing bacteria is a key pathogenic feature of alcohol-induced functional gut microbial dysbiosis and development of liver disease in mice. Gut Microbes. 2021;13(1):1946367. https:\/\/doi.org\/10.1080\/19490976.2021.1946367.","journal-title":"Gut Microbes"},{"issue":"6086","key":"5421_CR37","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","volume":"336","author":"JK Nicholson","year":"2012","unstructured":"Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336(6086):1262\u20137. https:\/\/doi.org\/10.1126\/science.1223813.","journal-title":"Science"},{"issue":"5","key":"5421_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.nutres.2008.02.012","volume":"28","author":"M Usami","year":"2008","unstructured":"Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res. 2008;28(5):321\u20138. https:\/\/doi.org\/10.1016\/j.nutres.2008.02.012.","journal-title":"Nutr Res"},{"key":"5421_CR39","doi-asserted-by":"publisher","unstructured":"Baumann A, Jin CJ, Brandt A, Sellmann C, Nier A, Burkard M, et al. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Nutrients. 2020;12(4). https:\/\/doi.org\/10.3390\/nu12040951.","DOI":"10.3390\/nu12040951"},{"issue":"6","key":"5421_CR40","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1111\/acer.12428","volume":"38","author":"GA Cresci","year":"2014","unstructured":"Cresci GA, Bush K, Nagy LE. Tributyrin supplementation protects mice from acute ethanol-induced gut injury. Alcohol Clin Exp Res. 2014;38(6):1489\u2013501. https:\/\/doi.org\/10.1111\/acer.12428.","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"5421_CR41","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1021\/acs.molpharmaceut.8b00347","volume":"15","author":"Y Li","year":"2018","unstructured":"Li Y, Liu T, Yan C, Xie R, Guo Z, Wang S, et al. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier. Mol Pharm. 2018;15(9):3860\u201370. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.8b00347.","journal-title":"Mol Pharm"},{"key":"5421_CR42","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.metabol.2017.02.003","volume":"70","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shou JW, Li XY, Zhao ZX, Fu J, He CY, et al. Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism. Metabolism. 2017;70:72\u201384. https:\/\/doi.org\/10.1016\/j.metabol.2017.02.003.","journal-title":"Metabolism"},{"issue":"3","key":"5421_CR43","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/ismej.2015.151","volume":"10","author":"R Berni Canani","year":"2016","unstructured":"Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 2016;10(3):742\u201350. https:\/\/doi.org\/10.1038\/ismej.2015.151.","journal-title":"ISME J"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-026-05421-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05421-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-026-05421-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:52:50Z","timestamp":1784253170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12906-026-05421-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5421"],"URL":"https:\/\/doi.org\/10.1186\/s12906-026-05421-3","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were conducted following the guidelines of the Animal Ethics Committee of Yunnan University of Chinese Medicine (approval No. R-062021LH-130).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"229"}}